What is NAD+?

• NAD+, also known as nicotinamide adenosine dinucleotide, is a coenzyme found in the cells of our body. It metabolizes carbohydrates, fats, and amino acids and plays a role with gene expression in age related diseases.

What are the benefits of NAD+?

• Boost metabolism and energy.

• Reduces chronic pain. (1)

• Helps regenerate and heal cells.

• Promising therapy for addiction recovery. (1)

• Reduce cravings associated with alcohol and opiate withdrawal. (1, 7)

• Improve mental clarity, memory and mood. (2)

• Brain regeneration and repair. (2)

• Regulates inflammation and DNA protection through sirtuin pathway. (3,4)

• Slows the aging process.

Why NAD+ IV Therapy?

• IV Therapy yields a high dose of NAD+ directly into your bloodstream to give you effective results quickly, naturally and safely. (5)

• Your energy production is optimized through direct impact on ATP production in your cells mitochondria. (6)

• The results can last days to weeks depends on your current health condition.

Our formula contains:

• Vitamins, Minerals, and Amino Acids in an electrolyte mixture to enhance the recycling and efficacy of the NAD+

• NAD+: 500 mg

• Glutathione: the primary antioxidant produced in your body

• The IV is infused over 2-4 hours

References:
1. Humiston J (2014). “Treatment of Drug and Alcohol Dependence and Chronic Pain with Intravenous Amino Acids.” Meeting of the Int’l College of Integrative Medicine, Dearborn, Michigan, 25 Sept. 2014.
2. Billington RA, Bruzzone S, De Flora A, Genazzani AA, Koch-Nolte F, Ziegler M, Zocchi E (2006). "Emerging functions of extracellular pyridine nucleotides." Mol Med. 12 (11–12): 324–7.
3. Bürkle A (2005). "Poly(ADP-ribose). The most elaborate metabolite of NAD+." FEBS J. 272 (18): 4576–89.
4. Blander G, Guarente L (2004). "The Sir2 family of protein deacetylases." Annu. Rev. Biochem. 73: 417–35.
5. Birkmayer JG, Nadlinger KF, Hallström S. On the safety of reduced nicotinamide adenine dinucleotide (NADH). J Environ Pathol Toxicol Oncol. 2004;23(3):179-94.
6. Forsyth LM, Preuss HG, MacDowell AL, Chiazze L Jr, Birkmayer GD, Bellanti JA. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. Ann Allergy Asthma Immunol. 1999 Feb;82(2):185-91.

7. John E. Humiston, M.D. Diplomate, ABFM, “FDA Pharmacy Compounding Committee Review: Nicotinamide Adenine Dinucleotide (NAD+)” https://www.fda.gov/media/113016/download